Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 250
- 试验地点
- 2
- 主要终点
- Rate of correctly predicted cases of acute mesenteric ischaemia
研究概览
简要总结
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 years or older
- •Initial decision in favour of further diagnostics of mesenteric ischaemia
排除标准
- •Age <18 years
- •Consent declined by patient or next of kin (delayed consent)
- •Chronic mesenteric ischaemia without an acute event
- •Immediate decision for withdrawal of further diagnostics and active treatment
- •Referral from another hospital with already established diagnosis of AMI
- •AMI diagnosed at surgery without previously having been considered
研究组 & 干预措施
Patient with suspicion of acute mesenteric ischaemia
Bolld samples is the only intervention. All patients with suspicion of AMI will be included and blood samples collected
干预措施: Sequential blood samples (Diagnostic Test)
结局指标
主要结局
Rate of correctly predicted cases of acute mesenteric ischaemia
时间窗: 10 months
Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers
次要结局
未报告次要终点
研究者
Annika Reintam Blaser
Associate Professor
University of Tartu
